Other Content - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Other Content

Pfizer Restructuring a Boon to CMOs and CROs

March 2, 2007

Pharmaceutical Technology

As big pharmaceutical companies restructure and reevaluate the way they do business, contract research and manufacturing organizations could reap greater financial rewards.

Will Delivery Technologies Deliver Profits to CMOs?...

October 2, 2006

Special from Pharmaceutical Technology

More CMOs look to proprietary delivery technologies to enhance profitability.

First Impressions...

July 2, 2006

Special from Pharmaceutical Technology

China is on the rise as a center for pharmaceutical R&D, but companies are still getting their footing for operating in China and the services industry has some maturing to do.

Here's to a Strong 2006!

January 1, 2006

Pharmaceutical Technology

The big question for pharmaceutical services providers coming into 2006 is: will the good times continue to roll?

Compounding Pharmacies' Lawsuit Against FDA Will Continue

May 27, 2005
Pharmaceutical Technology

Compounding Pharmacies' Lawsuit Against FDA Will Continue

Outsourcing Outlook

June 1, 2002

Pharmaceutical Technology

The author discusses the upcoming human research congressional debate and CROs' preparations to respond.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here